The prevalence of daily low-dose aspirin use fell significantly after the American College of Cardiology and the American Heart Association narrowed ...

People without the risk of heart problems who consumed daily low-dose aspirin, it increased the chance of bleeding in the ...

Scientists have made 'exciting,' patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly into tumors. This emerging technology holds ...

nevertheless, there was a small but statistically significant increase in major GI bleeding (47 [0.4%] vs 29 [0.2%]; p = 0.04) with high-dose versus low-dose aspirin.

Scientists at UMass Amherst and Ernest Pharmaceuticals developed BacID, a bacterial cancer therapy activated by aspirin. This ...

Among patients taking aspirin, the use of 12 weeks of famotidine ... prostaglandin analogues, warfarin, high-dose steroids, cytotoxic drugs, nonsteroidal anti-inflammatory drugs, or bisphosphonates ...

A University of Massachusetts Amherst-Ernest Pharmaceuticals team of scientists has made "exciting," patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver ...

Expected to begin in 2027, the trials will involve human patients, and the researchers are working to obtain the necessary ...

I have been having a sensation of ringing in my ears for the past few months. The doctors gave a diagnosis of tinnitus, ...

Over-the-counter painkillers provide quick relief for many common ailments, making them a staple in medicine cabinets ...

Lynch syndrome, a genetic condition caused by germline mutations in DNA mismatch repair genes, significantly increases cancer ...